Back to Journals » OncoTargets and Therapy » Volume 6

Review

Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC

       
Total article views   HTML views PDF downloads Totals
21,683 Dovepress* 13,559+ 3,201 16,760
PubMed Central* 8,124 2,166 10,290
Totals 21,683 5,367 27,050
*Since 5 March 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar